| Trial Name | Description |
| SPARTACUS II |
Dr. D. D'Souza Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus II: A Phase II Randomized Controlled Trial |
| ENC.1 GYN |
Dr. Stephen Welch A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer. |
| CAN-STAMP GYN |
Dr. Jacob McGee Canadian multi-arm multi-stage randomized controlled trial assessing front line treatment in serous or p53 mutant endometrial cancer (CAN-STAMP). |
| EPIK-O GYN |
Dr. S. Welch A Phase III, multi-center, randomized (1:1), open-label, active controlled study to assess the efficacy and safety of alpelisib (BYL719) in combination with olaparib as compared to single agent cytotoxic chemotherapy, in participants with n |
| FONTANA MS (GYN & Lung) |
Dr. S. Welch A Modular Phase I/IIA, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Ascending Doses of AZD5335 Monotherapy and in Combination with Anit-Cancer Agents in Patients with Solid T |
| Keynote 826 |
Dr. Stephen Welch A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Chemotherapy Plus Placebo for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer (KEYNOTE-826). |
| SIENDO GYN |
Dr. S. Welch A Randomized, Double-Blind, Phase 3 Trial of Maintenance with Selinexor/Placebo after Combination Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer |
| ARTISTRY-7 GYN |
Dr. Stephen Welch A Phase 3, Multicenter, Open-Label, Randomized Study of Nemvaleukin Alfa in Combination With Pembrolizumab Versus Investigator's Choice Chemotherapy in Patients With Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritone |
| SPARTACUS |
Dr. David D'Souza Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus: A Phase 1 Pilot Study (SPARTACUS) |
| HEROICC GYN |
Dr. Lucas Mendez Hypofractionated External-beam RadiOtherapy for Intact Cervical Cancer (HEROICC-Trial): A Feasibility Study |
| IND.243 |
Dr. Stephen Welch A Phase II Study of RP-6306 in Patients with Advanced Cancer. |
| EN.11 GYN |
Dr. Stephen Welch RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials - MMRd-GREEN |
| EN.10 GYN RAINBO BLUE & TAPER |
Dr. L. Mendez A Phase II Study of Tailored Adjuvant Therapy in POLE-Mutated and p-53-Wildtype/NSMP Early Stage Endometrial Cancer |